Influenza News and Research

Latest Influenza News and Research

FDA continues to support the development of medical products to tackle new virus variants

As the public health agency responsible for regulating medical products, we must ensure that health care providers have the most up-to-date diagnostics, treatments and vaccines in their toolbox to fight this pandemic.

5 Feb 2021

Natural reinfection with respiratory syncytial virus varies based on antibody response

Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a typical sustained antibody response associated with protection, a few individuals surprisingly responded atypically, not being able to sustain the antibody response, which declined to levels that made the individuals susceptible to RSV reinfection.

5 Feb 2021

Study indicates that 2019-2020 flu season was driven by a new, more transmissible strain

The 2019-2020 flu season in the U.S. was unusual in a number of ways. Cases picked up in August rather than the more typical fall and early winter months, and it hit children particularly hard. It was also dominated early on by a Type B influenza virus instead of one of the much more common Type A viruses like H1N1 or H3N2.

5 Feb 2021

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

A new preprint posted to the bioRxiv server demonstrates that similar mucins and mucin-like proteins cannot only suppress HIV-1 infectivity via blockage of viral attachment to the host cells but can block infection by multiple enveloped viruses.

4 Feb 2021

Seasonal flu shots reduce COVID-19 symptoms in children

Researchers from the University of Missouri School of Medicine have discovered that children who receive a seasonal flu shot are less likely to suffer symptoms from a COVID-19 infection. The finding comes from a review of more than 900 children diagnosed with COVID-19 in 2020.

4 Feb 2021

Researchers call for trials of rapamycin to treat COVID-19

Researchers in the United States, China, and the UK have called for immediate large-scale clinical trials of an antibiotic called rapamycin as a prophylactic and treatment approach to coronavirus disease 2019 (COVID-19) in older individuals.

4 Feb 2021

What are public preferences for COVID-19 vaccine prioritization strategies across the globe?

Researchers describe the results of a novel survey that asked members of the public in a range of countries for their thoughts on prioritization measures for vaccination programs against COVID-19.

4 Feb 2021

Study shows how SARS-CoV-2 evades immune responses

In a recurring pattern of evolution, SARS-CoV-2 evades immune responses by selectively deleting small bits of its genetic sequence, according to new research from the University of Pittsburgh School of Medicine.

4 Feb 2021

Predicting future mamalian hosts of SARS-CoV-2

Researchers at the Beijing Computational Science Research Center and Peking University analyzed sequences of the angiotensin-converting enzyme 2 (ACE2) proteins from 16 mammals and predicted the structures of ACE2- receptor-binding domain (RBD) complexes.

4 Feb 2021

Survey finds 41% of United States residents unwilling to receive a COVID-19 vaccine

A cross-sectional online survey conducted by the scientists of Johns Hopkins Bloomberg School of Public Health, USA, has revealed that about 41% of US residents are unwilling to receive a coronavirus disease 2019 (COVID-19) vaccine due to concern over vaccine safety and efficacy. Moreover, there are sub-group variations in willingness to receive a COVID-19 vaccine

3 Feb 2021

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.

3 Feb 2021

Experimental intranasal influenza vaccine produces durable immune response

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation.

3 Feb 2021

Genomic study suggests SARS-CoV-2 clade 20C was imported into Japan from the US

A new study describes the outcome of such sequencing efforts in Japan as an important tool towards containing the spread of the infection.

3 Feb 2021

Immune profiling shows differences in COVID-19 and influenza pathologic pathways

A study conducted at Johns Hopkins University School of Medicine in Baltimore has revealed distinct differences in the immune pathways that are activated by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and those that are activated by influenza.

2 Feb 2021

Pfizer-BioNTech vaccine shows promise against new SARS-CoV-2 variants

A team of researchers in the U.S. studied the Pfizer-BioNTech vaccine candidate - currently being rolled out in many parts of the world to high-risk individuals - to see if it still holds up against mutant strains of the virus and yielded encouraging results.

2 Feb 2021

Differences in immune response to SARS-CoV-2 determine disease severity, study finds

Researchers investigate host responses to SARS-CoV-2, respiratory syncytial virus (RSV), and influenza virus (IV) in the nasal mucosa in children and adults.

2 Feb 2021

When your chance for a covid shot comes, don’t worry about the numbers

When getting vaccinated against covid-19, there's no sense being picky. You should take the first authorized vaccine that's offered, experts say.

1 Feb 2021

Studies show slowing of UK life expectancy after financial crisis

Increases in life expectancy in the UK and elsewhere had slowed even before 2016 - and COVID-19 is expected to further eliminate any gains, Newcastle University studies show.

1 Feb 2021

India’s COVID-19-related hygiene promotion campaign shows some positive results

A new study explores the results of such hygiene promotion campaigns on handwashing practices in rural Odisha, India.

1 Feb 2021

E484K mutation is potentially associated with SARS-CoV-2 adaptive fitness

A team of Brazilian scientists has recently conducted genomic and phylogenetic analyses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome to understand the viral evolution process better. Their analyses reveal that the E484K mutated variant of SARS-CoV-2 is present in three different lineages in four Brazilian regions and that the mutation may serve as a common solution for viral evolution.

31 Jan 2021

Influenza News and Research

Latest Influenza News and Research

FDA continues to support the development of medical products to tackle new virus variants

Natural reinfection with respiratory syncytial virus varies based on antibody response

Study indicates that 2019-2020 flu season was driven by a new, more transmissible strain

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

Seasonal flu shots reduce COVID-19 symptoms in children

Researchers call for trials of rapamycin to treat COVID-19

What are public preferences for COVID-19 vaccine prioritization strategies across the globe?

Study shows how SARS-CoV-2 evades immune responses

Predicting future mamalian hosts of SARS-CoV-2

Survey finds 41% of United States residents unwilling to receive a COVID-19 vaccine

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Experimental intranasal influenza vaccine produces durable immune response

Genomic study suggests SARS-CoV-2 clade 20C was imported into Japan from the US

Immune profiling shows differences in COVID-19 and influenza pathologic pathways

Pfizer-BioNTech vaccine shows promise against new SARS-CoV-2 variants

Differences in immune response to SARS-CoV-2 determine disease severity, study finds

When your chance for a covid shot comes, don’t worry about the numbers

Studies show slowing of UK life expectancy after financial crisis

India’s COVID-19-related hygiene promotion campaign shows some positive results

E484K mutation is potentially associated with SARS-CoV-2 adaptive fitness

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in